Literature DB >> 23499503

Identification of pyrrolo[2,3-g]indazoles as new Pim kinase inhibitors.

Laurent Gavara1, Virginie Suchaud, Lionel Nauton, Vincent Théry, Fabrice Anizon, Pascale Moreau.   

Abstract

The synthesis and Pim kinase inhibition potency of a new series of pyrrolo[2,3-g]indazole derivatives is described. The results obtained in this preliminary structure-activity relationship study pointed out that sub-micromolar Pim-1 and Pim-3 inhibitory potencies could be obtained in this series, more particularly for compounds 10 and 20, showing that pyrrolo[2,3-g]indazole scaffold could be used for the development of new potent Pim kinase inhibitors. Molecular modeling experiments were also performed to study the binding mode of these compounds in Pim-3 ATP-binding pocket.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23499503     DOI: 10.1016/j.bmcl.2013.02.074

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  4 in total

1.  Direct C7 Functionalization of Tryptophan. Synthesis of Methyl (S)-2-((tert-Butoxycarbonyl)amino)-3-(7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indol-3-yl)propanoate.

Authors:  Kazuma Amaike; Richard P Loach; Mohammad Movassaghi
Journal:  Organic Synth       Date:  2015

Review 2.  Pathophysiological roles of Pim-3 kinase in pancreatic cancer development and progression.

Authors:  Ying-Yi Li; Naofumi Mukaida
Journal:  World J Gastroenterol       Date:  2014-07-28       Impact factor: 5.742

3.  Tetrahydroindazole inhibitors of CDK2/cyclin complexes.

Authors:  Jae Chul Lee; Kwon Ho Hong; Andreas Becker; Joseph S Tash; Ernst Schönbrunn; Gunda I Georg
Journal:  Eur J Med Chem       Date:  2021-01-31       Impact factor: 6.514

4.  C7-derivatization of C3-alkylindoles including tryptophans and tryptamines.

Authors:  Richard P Loach; Owen S Fenton; Kazuma Amaike; Dustin S Siegel; Erhan Ozkal; Mohammad Movassaghi
Journal:  J Org Chem       Date:  2014-11-10       Impact factor: 4.354

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.